The evidence that PTEN interacts with the PAFR pathway came from the earlier report demonstrating that treatment with a specific PAFR antagonist, WEB2086 to breast carcinoma MCF-7 and MDA-MB-231 cell lines causes G0/G1 cell cycle arrest [29]. This evidence concerns the gene PTAFR and breast carcinoma.